Province of British Columbia
40th Parliament – 2013
Select Standing Committee on Health
INDEX

Walman, Barbara

Presentation to committee on behalf of Health Ministry 4:1040-1125, 4:1135-1200
AIDS
prescription drug coverage 4:1120
Botox
coverage under Pharmacare program 4:1145
B.C. Cancer Agency
role in drug review process 4:1150-1155
B.C. services card
role in fraud prevention 4:1150
Canadian Agency for Drugs and Technologies in Health
role and funding 4:1040
Cancer
chemotherapy drugs, coverage under PharmaCare program 4:1150-1155
Children
prescription drug coverage for children receiving medical care at home 4:1120-1125
Cystic fibrosis
prescription drug coverage 4:1120-1125
Disease
prescription drug treatment and coverage 4:1040, 4:1055-1100, 4:1120, 4:1135
Drug Benefit Council
role in drug review process 4:1045-1055
Drugs, prescription drugs
costs and spending
public and private spending 4:1100-1105
public opinion and research 4:1155
fraud prevention 4:1150
prescribers
education and information, academic detailing program 4:1100
prices and cost management
high-cost and specialty drugs 4:1140, 4:1155-1200
national purchasing alliance 4:1045-1050, 4:1200
prices and cost management 4:1140
public education and information 4:1045-1055
review process
common drug review 4:1040-1055, 4:1155
Health Canada
role in drug review process 4:1040
Health, health care system
patient-centred care 4:1140
Health Ministry
pharmaceutical services division 4:1040
role in drug review process 4:1145
Hospice and palliative care
prescription drug coverage 4:1120
Housing, residential care facilities
prescription drug coverage for residents 4:1120-1125
Income assistance
recipients, prescription drug coverage 4:1120-1125
MLAs
constituency offices, information on PharmaCare program 4:1110
Mental health
prescription drug coverage for mental illness 4:1120-1125
PharmaCare program
challenges and opportunities 4:1140
costs and spending, factors and trends 4:1105-1110, 4:1120-1125, 4:1135-1140
coverage
coverage plans 4:1105, 4:1115-1125
income-based coverage and deductibles 4:1110-1115
medical equipment and supplies 4:1105, 4:1135
regular, partial and limited coverage 4:1135
scope 4:1100-1105, 4:1115-1120
drug approval process 4:1040-1100, 4:1145
changes since 2009 4:1045
decisions in 2012-13 4:1055, 4:1145
evaluation of health and cost factors 4:1155
implementation of decisions 4:1055
information and transparency 4:1045-1050, 4:1155-1200
therapeutic reviews 4:1055
timeline 4:1045, 4:1055
website for patient input 4:1050-1055
enrolment 4:1110, 4:1125
Fair PharmaCare plan 4:1110-1115, 4:1125
formulary of eligible drugs
online formulary 4:1050
scope and excluded drugs 4:1040
PharmaNet information system 4:1135
public engagement and information 4:1045-1055, 4:1110, 4:1155-1200
special authority program 4:1135
Pharmaceutical Services Act
regulations 4:1110
Pharmaceutical Task Force
recommendations 4:1045
Pharmacists
fees and services, coverage under PharmaCare program 4:1105, 4:1120-1125
scope of practice, expansion 4:1140-1145
Physicians
prescription of drugs, telephone prescription 4:1150
Seniors
prescription drug coverage 4:1105
Tobacco
smoking cessation program, coverage under Pharmacare program 4:1120
Werker, Greg

Work on patient flow models (Anis, A.) 3:1430-1435

Copyright Information | top of page